7.5.2DASection
Pharmacology
lines 3406–3406id: 7.5.2
7 items
- 7.5.2.1DAPharmacology of oxytocic agents with special reference to oxytocin derivatives (including carbetocin), ergot derivatives and prostaglandins
- 7.5.2.2DAPharmacology of tocolytic agents, with specific reference to beta-2 agonists, calcium antagonists, magnesium, inhalational anaesthetics, nitrates and non-steroidal anti- inflammatory medications (NSAIDs)
- 7.5.2.3DAPharmacology of agents used for the treatment of preeclampsia, including nifedipine, magnesium, hydralazine, labetalol and other antihypertensives
- 7.5.2.4DAFactors that influence the transfer of medications across the placenta and into breast milk
- 7.5.2.5DAPotential effects on the foetus and neonate of medications administered during pregnancy
- 7.5.2.6DAMinimum alveolar concentration (MAC) and local anaesthetic adjustments during pregnancy
- 7.5.2.7DAMedications for hypotension management, including neuraxial-induced hypotension